Nuclear translocation of ATBF1 is a potential prognostic marker for skin cancer

Acta Dermatovenerologica Croatica

Volumn 20, Issue 4, 2012, Pages 239-245

  Nishio, Eiichi ^a   Miura, Yutaka ^a   Kawaguchi, Makoto ^b   Morita, Akimichi ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b Japan Organization of Occupational Health and Safety   (Japan)

Author keywords

ATBF 1; Basal cell carcinoma; Bowen's disease; Squamous cell carcinoma

Indexed keywords

AT MOTIF BINDING FACTOR 1; BIOLOGICAL MARKER; REGULATOR PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; CANCER PROGNOSIS; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROTEIN TRANSPORT; SKIN CANCER; SQUAMOUS CELL CARCINOMA;

BOWEN'S DISEASE; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; SKIN NEOPLASMS; TRANSLOCATION, GENETIC;

EID: 84872343676     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Ishii Y, Kawaguchi M, Takagawa K, Oya T, Nogami S, Tamura A, et al. ATBF1-A protein, but not ATBF1- B, is preferentially expressed in developing rat brain. J Comp Neurol 2003;465:57-71.
2. Miura Y, Kataoka H, Joh T, Tada T, Asai K, Nakanishi M, et al. Susceptibility to killer T cells of gastric cancer cells enhanced by mitomycin-C involves induction of ATBF1 and activation of p21 (Waf1/ Cip1) promoter. Microbiol Immunol 2004;48:137-145.
3. Kataoka H, Miura Y, Joh T, Seno K, Tada T, Tamaoki T, et al. Alpha-fetoprotein producing gastric cancer lacks transcription factor ATBF1. Oncogene 2001;20:869-873.
4. Morinaga T, Yasuda H, Hashimoto T, Higashio K, Tamaoki T. A human alpha-fetoprotein enhancerbinding protein, ATBF1, contains four homeodomains and seventeen zinc fingers. Mol Cell Biol 1991;11:6041-6049.
5. Yamada K, Miura Y, Scheidl T, Yoshida MC, Tamaoki T. Assignment of the human ATBF1 transcription factor gene to chromosome 16q22.3-q23.1. Genomics 1995;29:552-553.
6. Kai K, Zhang Z, Yamashita H, Yamamoto Y, Miura Y, Iwase H. Loss of heterozygosity at the ATBF1-A locus located in the 16q22 minimal region in breast cancer. BMC Cancer 2008;8:262.
7. Lange EM, Beebe-Dimmer JL, Ray AM, Zuhlke KA, Ellis J, Wang Y, et al. Genome-wide linkage scan for prostate cancer susceptibility from the University of Michigan Prostate Cancer Genetics Project: suggestive evidence for linkage at 16q23. Prostate 2009;69:385-391.
8. Sun X, Frierson HF, Chen C, Li C, Ran Q, Otto KB, et al. Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer. Nat Genet 2005;37:407-412. Erratum in: Nat Genet 2005;37:652.
9. Miura Y, Tam T, Ido A, Morinaga T, Miki T, Hashimoto T, et al. Cloning and characterization of an ATBF1 isoform that expresses in a neuronal differentiation- dependent manner. J Biol Chem 1995;270:26840-6848.
10. Cho YG, Song JH, Kim CJ, Lee YS, Kim SY, Nam SW, et al. Genetic alterations of the ATBF1 gene in gastric cancer. Clin Cancer Res 2007;13:4355-4359.
11. Zhang Z, Yamashita H, Toyama T, Sugiura H, Ando Y, Mita K, et al. ATBF1-a messenger RNA expression is correlated with better prognosis in breast cancer. Clin Cancer Res 2005;11:193-198.
12. Dong X-Y, Sun X, Guo P, Li Q, Sasahara M, Ishii Y, et al. ATBF1 inhibits estrogen receptor (ER) function by selectively competing with AIB1 for binding to ER in ER-positive breast cancer cells. J Biol Chem 2010;285:32801-2809.
13. Nojiri S, Joh T, Miura Y, Sakata N, Nomura T, Nakao H, et al. ATBF1 enhances the suppression of STAT3 signaling by interaction with PIAS3. Biochem Biophys Res Commun 2004;314:97-103.
14. Sano S, Chan KS, Carbajal S, Clifford J, Peavey M, Kiguchi K, et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 2005;11:43-49.
15. Liu ZL, Li Y, Kong QY, Zhan C, Wang Q, Chen XY, et al. Immunohistochemical profiling of Wnt, NFkappaB, Stat3 and Notch signaling in human epidermal tumors. J Dermatol Sci 2008;52:133-136.
16. Muchemwa FC, Nakatsura T, Ihn H, Kageshita T. Heat shock protein 105 is overexpressed in squamous cell carcinoma and extramammary Paget disease but not in basal cell carcinoma. Br J Dermatol 2006;155:582-585.
17. Trautinger F, Kindas-Mügge I, Dekrout B, Knobler RM, Metze D. Expression of the 27-kDa heat shock protein in human epidermis and in epidermal neoplasms: an immunohistological study. Br J Dermatol 1995;133:194-202.